tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Immunotech Biopharm Schedules Key Financial Review

Immunotech Biopharm Schedules Key Financial Review

Immunotech Biopharm Ltd (HK:6978) has released an update.

Elevate Your Investing Strategy:

Immunotech Biopharm Ltd is set to hold a board meeting on August 23, 2024, to review and approve its interim financial results for the first half of the year. This announcement comes as the company prepares to publish its performance data for the period ending June 30, 2024. The meeting will be a pivotal moment for shareholders and potential investors to gauge the company’s current financial health.

For further insights into HK:6978 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1